Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke

Acta Neurologica Scandinavica

Volumn 116, Issue 3, 2007, Pages 144-149

  Piechowski Jozwiak B ^a   Mickielewicz, A ^a   Gaciong, Z ^a   Berent, H ^a   Kwiecinski H ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cerebrovascular disorders; Chlamydia pneumoniae; Infection; Stroke

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SCORING SYSTEM; SEROLOGY; SEX DIFFERENCE;

ADULT; AGE FACTORS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34547922028     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00819.x     Document Type: Article

References (38)

1. Cosentini R, Blasi F. New pathogens for respiratory infections. Curr Opin Pulm Med 1996 2 : 174 180.
2. Thomas M, Wong Y, Thomas D et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 1999 99 : 2733 2736.
3. Shor A, Phillips JI, Ong G, Thomas BJ, Taylor-Robinson D. Chlamydia pneumoniae in atheroma: consideration of criteria for causality. J Clin Pathol 1998 51 : 812 817.
4. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999 138 (5 Pt 2 S534 S536.
5. Virok D, Kis Z, Karai L et al. Chlamydia pneumoniae in atherosclerotic middle cerebral artery. Stroke 2001 32 : 1973 1976.
6. Valassina M, Migliorini L, Sansoni A et al. Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries. J Med Microbiol 2001 50 : 228 232.
7. Vink A, Poppen M, Schoneveld AH et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001 103 : 1613 1617.
8. Tarnacka B, Gromadzka G, Czlonkowska A. Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus. Stroke 2002 33 : 936 940.
9. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998 29 : 404 410.
10. Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke 2000 31 : 1521 1525.
11. Madre JG, Garcia JL, Gonzalez RC et al. Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002 9 : 303 306.
12. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996 27 : 2207 2210.
13. Elkind MS, Tondella ML, Feikin DR, Fields BS, Homma S, Di Tullio MR. Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke. Stroke 2006 37 : 790 795.
14. Johnsen SP, Overvad K, Ostergaard L, Tjonneland A, Husted SE, Sorensen HT. Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study. Eur J Epidemiol 2005 20 : 59 65.
15. Njamnshi AK, Blackett KN, Mbuagbaw JN, Gumedze F, Gupta S, Wiysonge CS. Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study. Stroke 2006 37 : 796 799.
16. Anzini A, Cassone A, Rasura M et al. Chlamydia pneumoniae infection in young stroke patients: a case-control study. Eur J Neurol 2004 11 : 321 327.
17. Haider AW, Wilson PW, Larson MG et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol 2002 40 : 1408 1413.
18. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976 54 : 541 553.
19. Adams HP Jr., Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993 24 : 35 41.
20. Heuschmann PU, Neureiter D, Gesslein M et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke 2001 32 : 2253 2258.
21. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J. Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999 30 : 299 305.
22. Hahn DL, Anttila T, Saikku P. Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma. Epidemiol Infect 1996 117 : 513 517.
23. Dowell SF, Peeling RW, Boman J et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001 33 : 492 503.
24. Ngeh J, Gupta S, Goodbourn C, Panayiotou B, McElligott G. Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease. Cerebrovasc Dis 2003 15 : 11 16.
25. Ngeh J, Goodbourn C. Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrovascular disease. Stroke 2005 36 : 259 265.
26. Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994 23 : 1315 1321.
27. Prager M, Turel Z, Speidl WS et al. Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke 2002 33 : 2756 2761.
28. Numazaki K, Ikebe T, Chiba S. Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol 1996 14 : 179 183.
29. Vehmaan-Kreula P, Puolakkainen M, Sarvas M, Welgus HG, Kovanen PT. Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2001 21 : E1 E8.
30. Song YG, Kwon HM, Kim JM et al. Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae. Yonsei Med J 2000 41 : 319 327.
31. Loftus IM, Naylor AR, Bell PR, Thompson MM. Plasma MMP-9 - a marker of carotid plaque instability. Eur J Vasc Endovasc Surg 2001 21 : 17 21.
32. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev 2000 8 : 31 39.
33. Sander D, Winbeck K, Klingelhofer J, Etgen T, Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 2002 106 : 2428 2433.
34. Hashimoto N, Kawabe T, Hara T et al. Effect of erythromycin on matrix metalloproteinase-9 and cell migration. J Lab Clin Med 2001 137 : 176 183.
35. Cannon CP, Braunwald E, McCabe CH et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 2005 352 : 1646 1654.
36. Grayston JT, Kronmal RA, Jackson LA et al. Azithromycin for the secondary prevention of coronary events. N Engl J Med 2005 352 : 1637 1645.
37. O'Connor CM, Dunne MW, Pfeffer MA et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003 290 : 1459 1466.
38. Ngeh J, Gupta S, Goodbourn C, McElligott G. Mycoplasma pneumoniae in elderly patients with stroke. A case-control study on the seroprevalence of M. pneumoniae in elderly patients with acute cerebrovascular disease - the M-PEPS Study. Cerebrovasc Dis 2004 17 : 314 319.